Arrêt de service programmé du vendredi 10 juin 16h jusqu’au lundi 13 juin 9h. Pour en savoir plus
Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery

Abstract :

Here, we report the in vivo proof of-concept of a novel nanocarrier, poly-l-asparagine (PASN) nanocapsules, as an anticancer targeted drug delivery system. The nanocapsules were loaded with the fluorescent marker DiD (1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine perchlorate) and also with the model drug docetaxel to evaluate the biodistribution and efficacy profiles in healthy and glioma-bearing mice, respectively. Regardless of their cargo, the nanocapsules presented a size close to 180 nm, a surface charge around -40 mV and an encapsulation efficiency of 75-90%. The biodistribution study in healthy mice showed that PASN nanocapsules led to a two- and three-fold increment in the mean residence time (MRT) and area under the curve (AUC) values, respectively, compared to those of a non-polymeric nanoemulsion. Finally, the efficacy/toxicity study indicated that the encapsulated drug was as efficacious as the commercial formulation (Taxotere(®)), with the additional advantage of being considerably less toxic. Overall, these results suggest the potential of PASN nanocapsules as drug nanocarriers in anticancer therapy.

Type de document :
Article dans une revue
Liste complète des métadonnées
Contributeur : Okina Univ Angers Connectez-vous pour contacter le contributeur
Soumis le : mercredi 24 mars 2021 - 09:49:55
Dernière modification le : mercredi 20 octobre 2021 - 03:19:23
Archivage à long terme le : : vendredi 25 juin 2021 - 18:20:56


Accord explicite pour ce dépôt




Gustavo Rivera-Rodriguez, Giovanna Lollo, Tristan Montier, Jean-Pierre Benoit, Catherine Passirani-Malleret, et al.. In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery. International Journal of Pharmaceutics, Elsevier, 2013, 458 (1), pp.83-9. ⟨10.1016/j.ijpharm.2013.09.038⟩. ⟨hal-03178899⟩



Consultations de la notice


Téléchargements de fichiers